Hospice valuation is under pressure, and big buyers are stepping back. If you’re ready to sell your hospice business, the right specialist matters. Vallexa Advisors guides you through hospice appraisal, steps to sell hospice, and captures maximum value with certainty.
Tag: valuation
EBITDA Multiples: How Vallexa Advisors Helps You Maximize Your Business Valuation
Understanding your EBITDA and its multiples is crucial to valuing your company. By leveraging peer groups such as Collective54 and partnering with Vallexa Advisors, business owners gain real-world benchmarks and expert guidance to sell confidently and for top dollar.
How to Sell My Healthcare Business with Confidence: Why Vallexa Advisors Is Your Best Partner
Looking to sell my healthcare business? Discover why Vallexa Advisors is the trusted M&A partner for healthcare owners, offering expert guidance, valuations, and buyer connections.
CMS Proposes 6.4% Medicare Payment Cut for 2026 — What Home Health Owners Should Do Now
On June 30, 2025, CMS proposed a 6.4% aggregate cut to Medicare home health payments for 2026. We break down what’s inside the rule, why it matters for margins and valuation, and the three strategies owners can act on now. Talk to Vallexa Advisors about defend, grow, or exit options.
The Real Value of Hiring an M&A Advisor: Why Owners See 25–37% Higher Valuations
Business owners who sell with an M&A advisor often achieve 25–37% higher valuations and millions more in net proceeds. Here’s why the right advisor changes everything.
The Essential Guide to Valuing Your Home Healthcare Agency
Accurate valuation is the foundation of growth, investment, and successful sales for Home Healthcare Agencies. This guide explores key valuation factors, preparation tips, and why working with Vallexa Advisors gives owners the clarity and confidence they need to maximize value.
What’s the Best Company to Sell a Hospice With?
Thinking about selling your hospice? In today’s fast-moving market, finding the right buyer matters. Vallexa Advisors has emerged as one of the top hospice buyers in 2024, completing acquisitions across multiple states with a focus on growth and care continuity. Learn why they should be on your radar.